Innovation Leadership Calloway Labs is at the forefront of clinical toxicology testing, utilizing advanced techniques such as high-volume screening, in-house GC/MS, and internet-based result delivery, positioning it as an innovative partner for laboratories seeking cutting-edge technology.

Market Growth Opportunity As one of the fastest-growing companies in its sector with revenues between 25 and 50 million dollars, Calloway presents a compelling opportunity for collaboration with vendors looking to expand into the expanding clinical toxicology testing market.

Regulatory Challenge Recent legal settlements related to False Claims Act and Anti-Kickback violations suggest an increased need for compliance and regulatory advisory services, opening doors for consulting firms specializing in healthcare regulations.

Acquisition & Investment Having been acquired by Ampersand Capital Partners, Calloway is positioned for further growth and potential partnership, making it a strategic target for investors and service providers seeking to support biotech and laboratory expansion.

Competitive Edge With a focus on proprietary testing protocols and integration with industry leaders, Calloway’s emphasis on technology and education indicates opportunities for technology vendors and training providers to offer specialized solutions.